TransCardiac Therapeutics, Inc.'s Chief Scientific Officer Presents Mitral Valve Repair Device at TCT Conference
TransCardiac Therapeutics Inc.'s ("TCT" or the "Company") Chief Scientific Officer, Dr. Omar Lattouf, was invited by the organizers of the Transcatheter Cardiovascular Therapeutics conference to present the Company's minimally invasive mitral valve repair device, the... - October 30, 2013
Press Releases 1 - 1 of 1